Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Deutsche Telekom and Broadcom expand partnership
-
IPG Photonics to Announce Third Quarter 2024 Financial Results on October 29
-
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi
-
Core Molding Technologies Announces Timing of Third Quarter Fiscal Year 2024 Results
-
Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
-
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need
-
Tree Island Steel to Issue Third Quarter 2024 Financial Results on November 5, 2024
-
CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies (DLB)
-
NetAlly Taps Channel Veteran Jeff McCullough to Drive Partner Sales Growth Across North America
-
JBTC Announces 3rd Quarter 2024 Earnings
-
Nametag Unveils Deepfake Defense™ to Combat AI-Powered Impersonation Threats, Expands Integration Partnership with Okta
-
American Rebel Light Beer Connecticut Launch Party at Toad’s Place Presented by Dichello Distributors
-
Wellspring Accelerates Growth Trajectory with Key C-Suite Appointments Following Sopheon Acquisition
-
Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology’s (ACG) 2024 Annual Scientific Meeting
-
Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
-
Concentrix Positioned as a Leader in Everest Group’s Customer Experience Management (CXM) Services PEAK Matrix® Assessment 2024
-
Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
-
Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
-
ScribeAmerica to Sponsor and Exhibit at the Inaugural AI @ HLTH Pavilion
-
Apollo Launches Evergreen Secondaries Products for Global Wealth Investors
-
GoHealth leveraging proprietary technology to help consumers navigate an unprecedented Annual Enrollment Period, as new data shows millions of Medicare beneficiaries face significant plan disruption
-
Apollo Closes Second Vintage Large Cap Direct Lending Fund with $4.8 Billion of Assets
-
Sloane & Company Expands its Healthcare Practice with the Appointment of Managing Director Leslie Wheeler
-
Blackford Capital Expands Its Patio Consolidation Platform with the Acquisition of Empire Distributing
-
Acronis and VirtualTech Celebrate the Opening of Escuela Rural Productiva in Mexico to Empower Local Youth Through Culturally Rich Education
-
Online Retailer Sticker Mule Moves AI Processing to the Rumble Cloud
-
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
-
FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs
-
Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
-
Pineapple Energy Announces Previously Approved Reverse Stock Split, Effective October 17, 2024
-
Provident Bank’s First-Time Home Buyer Survey Reveals That While Homeownership Continues to Be Challenging, Many Americans Are Finding Their Home in Less Than a Year
-
Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
-
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
-
More Than One-Third of Gig Workers Rely on Gig Work as Primary Source of Income
-
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024
-
atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
-
Second Gold for Regula at the Merit Awards for Cybersecurity
-
Extendicare Announces October 2024 Dividend of C$0.04 per Share
-
Vestaron Corporation Announces Strategic Collaboration with ADM for Production of Peptide-Based Crop Protection Products
-
AvantGuard, a Becklar Company, Raises Funds for Families in Need
-
WEC Energy Group Selects Lucasys Tax to Enhance Integration and Compliance Processes
-
GLMX Reports Third Quarter 2024 Activity
-
Talkspace to Report Third Quarter 2024 and Host Conference Call
-
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings
-
Michigan Schools Gain Free Access to STEM Career Exploration Tools
-
Nova Leap Health Corp. Announces Expansion to Florida With Execution of Definitive Agreement
-
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
-
ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome Inhibitors
-
Landstar to Release Third Quarter Results on Tuesday, October 29, 2024
-
Trailbreaker Initiates Multiple Geophysical Surveys at the Liberty Copper-Molybdenum Project, British Columbia
